NovaBay Pharmaceuticals, Inc. (NBY)

NYSEAMERICAN: NBY · Real-Time Price · USD

1.590

+0.100 (6.71%)

At close: Apr 1, 2026, 4:00 PM EDT

1.590

0.00 (0.00%)

After-hours: Apr 1, 2026, 8:00 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Eyecare & Wound Care			10.46M	10.24M	9.56M			-	-
Eyecare & Wound Care Growth			2.11%	7.16%	-			-	-
Skin Care			-	4.17M	649.00K			-	-
Skin Care Growth			-	541.76%	-			-	-
Commercializing Prescription Avenova for Managing Hygiene of The Eyelid & Lashes			-	-	-			12.51M	18.23M
Commercializing Prescription Avenova for Managing Hygiene of The Eyelid & Lashes Growth			-	-	-			-31.39%	53.23%
Total			10.46M	14.40M	10.20M			12.51M	18.23M
Total Growth			-27.42%	41.16%	-			-31.39%	53.23%

Source: S&P Global Market Intelligence.